TheWell Bioscience Launches RocketCell™ hMSC Xeno-Free Growth Medium

Got story updates? Submit your updates here. ›

TheWell Bioscience, a leader in advanced xeno-free cell culture technologies, has announced the launch of RocketCell™ hMSC Xeno-Free Complete Growth Medium, a chemically defined, xeno-free medium engineered for high-performance human mesenchymal stem cell (hMSC) expansion and exosome production across research, translational development, and cell therapy manufacturing workflows.

Why it matters

As regulatory agencies and industry leaders move toward standardized animal-component-free bioprocessing, the need for scalable, defined MSC culture systems has become increasingly urgent. Traditional serum-based MSC culture systems introduce variability, undefined signaling factors, and regulatory complexity—limiting reproducibility and clinical translation. RocketCell™ hMSC Xeno-Free Complete Growth Medium addresses these challenges with a 100% xeno-free, chemically defined formulation.

The details

RocketCell™ hMSC Xeno-Free Complete Growth Medium is designed to support high proliferation rates, enable efficient expansion at low seeding densities, maintain long-term stem cell potency, and improve scalability and cost-efficiency. The medium maintains classical hMSC markers and sustained tri-lineage differentiation capacity into adipogenic, chondrogenic, and osteogenic lineages after extended expansion.

• RocketCell™ hMSC Xeno-Free Complete Growth Medium was launched on March 4, 2026.

What they’re saying

What’s next

With the global MSC therapeutics market projected for significant growth over the next decade, scalable and defined expansion platforms like RocketCell™ hMSC Xeno-Free Complete Growth Medium are becoming increasingly critical to support translational pipelines and future commercial manufacturing.